InvestorsHub Logo

zoriden

12/03/13 6:44 PM

#5842 RE: Bob_the_Trader #5841

Patience is the hardest part.But I believe it will pay off profoundly. GLTY

Dennis48

12/03/13 8:29 PM

#5843 RE: Bob_the_Trader #5841

True Bob it would be great if the conference gets exposure for this very promising company. I bought a little more today... not because of the conference... just because I already am aware of the potential here and freed up some funds the other day to increase my position. It's a fine time to do that. Long ONCS

lasers

12/04/13 5:53 AM

#5845 RE: Bob_the_Trader #5841

If additional clinical results are available for Public information then the presenting Pharma will show an updated slide. Following from that would be a PR, news event, update for Shareholders. ONCS is looking for financial partner(s) especially to launch their EMA approved OMS ElectroImmunotherapy Neopulse bleomycin technology throughout Europe. ONCS EMA approved technology at 14,000 volts and localized Bleomycin is significantly different and potentially less chemo destructive than the EMA approved Italian IGEA 1000 volt Bleomycin intravenous technology.